איחוד האמירויות הערביות - אנגלית - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

piper nigrum (kalimirch) extract, tinospora cordifolia (guduchi) extract, cuminum cyminum (jeera) extract, zingiber officinale (sunthi) extract, emblica officinalis (amla) extract -

הממלכה המאוחדת - אנגלית - MHRA (Medicines & Healthcare Products Regulatory Agency)

ferndale pharmaceuticals ltd - lidocaine - cutaneous cream - 40mg/1gram

איחוד האמירויות הערביות - אנגלית - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

abcon international drug store llc india - 100ml bottle - syrup - combination - gastrointestinal system-dyspepsia , gord

איחוד האמירויות הערביות - אנגלית - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

abcon international drug store llc india - 100ml bottle - syrup - combination - gastrointestinal system-dyspepsia , gord

הודו - אנגלית - Central Drugs Standard Control Organization

hetero hc. - oint. - 15g

פיליפינים - אנגלית - FDA (Food And Drug Administration)

international pharmaceuticals, inc. - coleus amboinicus lour. (oregano leaf) - syrup - 125 mg/5 ml

מלזיה - אנגלית - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

ecolite biotech manufacturing sdn bhd - aster tataricus; cordyceps sinensis; cynanchum stauntonii; eriobotrya japonica; fritillaria cirrhosa; glycyrrhiza uralensis; momordica grosvenorii; morus alba; pinellia ternata; platycodon grandiflorum; prunus armeniaca; stemona sessilifolia; tussilago farfara; bird nest of collocalia esculenta -

דרום אפריקה - אנגלית - South African Health Products Regulatory Authority (SAHPRA)

the premier pharmaceutical co ltd - solution - each 5 ml contains sodium bicarbonate 87,5 mg sodium citrate 62,5 mg

פיליפינים - אנגלית - FDA (Food And Drug Administration)

coleus amboinicus lour (oregano leaf) - capsule - 375 mg

ארצות הברית - אנגלית - NLM (National Library of Medicine)

advanced pharmaceutical technology, inc. - estradiol (unii: 4ti98z838e) (estradiol - unii:4ti98z838e) - estradiol 50 mg - estradiol is indicated in the treatment of: 1. estrogen deficiency in hysterectomized women. (there is no evidence that estrogens are effective for nervous symptoms or depression which might occur during menopause, and they should not be used to treat these conditions.) 2. atrophic vaginitis. 3. kraurosis vulvae. 4. female hypogonadism. 5. female castration. 6. primary ovarian failure. 7. breast cancer (for palliation only) in approximately selected women and men with metastatic disease. 8. postpartum breast engorgement- althoughestrogens have been widely used for the prevention of postpatum breast engorgement, controlled studies hve demonstrated that the incidence of significapainful engorgementin patients not receiving such hormonal therapy is low and usually responsive to appropriate analgesic or other supportive therapy. consequently, the benefit to be derived from estrogen therapy for this indication must be carefully weighed against the potential increased risk or puerperal thromboembolism associated with the use of large doses of estrogen. 20,22 estradiol has not been shown to be effective for any purpose durig pregnancy and its use may cause severe harm to the fetus (see boxed warning). estrogens should not be used in women (or men) with any of the following conditions: 1. known or suspected cancer of the breast except in appropriately selected patients being treated for metastatic disease. 2. known or suspected estrogen-dependant neoplasia. 3. known or suspected pregnancy (see boxed warning). 4. undiagnosed abnormal genital bleeding. 5. active thrombophlebitis or thromboembolic disorders. 6. apast history of thrombophlebitis, thrombosis, or thromboembolic disorders associated with previous estrogen use (except when used in treatment of breast prostatic malignancy).